January 07, 2019

Pharma Partnering in China: What is a Deal Worth?

Pharma Partnering in China: What is a Deal Worth?

Chinese licensing partnerships are becoming both more common and more valuable, but the overall deal value for China remains relatively small.

Rare insight into the costs and opportunities in the Chinese market

We analyzed 92 licensing deals for pharmaceutical products in which China was the major territory for a foreign partner.
Some of the details contained in this report include:

  • • Total deal size;
  • • Upfront and equity payments;
  • • Development, commercial and total milestones;
  • • Royalties;
  • • Number of products in a deal;
  • • Therapeutic area and deal value;
  • • Phase of development and deal value.

Discover if partnering in China will be worthwhile for your company.

Get the PDF:
Pharma Partnering in China: What is a Deal Worth?

Sign-up below to gain access to the full report (PDF):


Business profiles tailored to your asset.